Why in news Union Health Ministry approved the introduction of a new treatment regimen for multidrug-resistant tuberculosis in India. T...
Why in news
Union Health Ministry approved the introduction of a new treatment regimen for multidrug-resistant tuberculosis in India.
The BPaLM regimen consists of four drugs — Bedaquiline, Pretomanid, Linezolid, and Moxifloxacin
Pretomanid had earlier been approved and licensed for use in India by the Central Drugs Standard Control Organisation.
While traditional treatments can last up to 20 months with severe side effects, the BPaLM regimen can cure drug-resistant TB in just six months with a high success rate
COMMENTS